CYBN Cybin | $10.03 +1.2% | 5/2/2024 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | Low | View details for Bloom Burton rating of Cybin (OTCMKTS:CYBN) on 5/2/2024 |
RPTX Repare Therapeutics | $3.35 -2.9% | 4/19/2024 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | Low | View details for Bloom Burton rating of Repare Therapeutics (NASDAQ:RPTX) on 4/19/2024 |
RPTX Repare Therapeutics | $3.35 -2.9% | 2/13/2024 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | Low | View details for Bloom Burton rating of Repare Therapeutics (NASDAQ:RPTX) on 2/13/2024 |
MBX Microbix Biosystems | C$0.32 +1.6% | 1/4/2024 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Microbix Biosystems (TSE:MBX) on 1/4/2024 |
ABCL AbCellera Biologics | $2.73 -1.8% | 11/3/2023 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | Low | View details for Bloom Burton rating of AbCellera Biologics (NASDAQ:ABCL) on 11/3/2023 |
MDP Medexus Pharmaceuticals | C$2.38 -6.7% | 6/26/2023 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | N/A | View details for Bloom Burton rating of Medexus Pharmaceuticals (TSE:MDP) on 6/26/2023 |
|
RX BioSyent | C$10.81 -3.9% | 3/23/2023 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/23/2023 |
DOC CloudMD Software & Services | C$0.04
| 11/16/2022 | Upgraded by | Bloom Burton | Analyst P. Pandurangan | Hold -> Accumulate | | N/A | View details for Bloom Burton rating of CloudMD Software & Services (CVE:DOC) on 11/16/2022 |
DOC CloudMD Software & Services | C$0.04
| 8/24/2022 | Downgraded by | Bloom Burton | Analyst P. Pandurangan | Buy -> Hold | | N/A | View details for Bloom Burton rating of CloudMD Software & Services (CVE:DOC) on 8/24/2022 |
MDNA Medicenna Therapeutics | C$2.36 +2.2% | 8/16/2022 | Target Lowered by | Bloom Burton | - | Buy | C$9.00 | N/A | View details for Bloom Burton rating of Medicenna Therapeutics (TSE:MDNA) on 8/16/2022 |
MDNA Medicenna Therapeutics | C$2.36 +2.2% | 7/28/2022 | Reiterated by | Bloom Burton | - | Buy | C$11.00 | N/A | View details for Bloom Burton rating of Medicenna Therapeutics (TSE:MDNA) on 7/28/2022 |
HLS HLS Therapeutics | C$3.34 -1.8% | 7/26/2022 | Reiterated by | Bloom Burton | - | Buy | C$22.00 | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 7/26/2022 |
MBX Microbix Biosystems | C$0.32 +1.6% | 6/6/2022 | Reiterated by | Bloom Burton | Analyst A. Borovina | Buy | | N/A | View details for Bloom Burton rating of Microbix Biosystems (TSE:MBX) on 6/6/2022 |
GUD Knight Therapeutics | C$5.64 +0.7% | 3/28/2022 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | C$6.70 | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 3/28/2022 |
GUD Knight Therapeutics | C$5.64 +0.7% | 3/25/2022 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 3/25/2022 |
RX BioSyent | C$10.81 -3.9% | 3/10/2022 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Accumulate | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/10/2022 |
DOC CloudMD Software & Services | C$0.04
| 12/22/2021 | Reiterated by | Bloom Burton | Analyst P. Pandurangan | Buy | | N/A | View details for Bloom Burton rating of CloudMD Software & Services (CVE:DOC) on 12/22/2021 |
ABCL AbCellera Biologics | $2.73 -1.8% | 12/19/2021 | Reiterated by | Bloom Burton | Analyst A. Borovina | Buy | | Low | View details for Bloom Burton rating of AbCellera Biologics (NASDAQ:ABCL) on 12/19/2021 |
AUPH Aurinia Pharmaceuticals | $7.21 -2.0% | 10/1/2021 | Initiated by | Bloom Burton | Analyst Prasath Pandurangan | Hold | $23.00 | Medium | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 10/1/2021 |
RPTX Repare Therapeutics | $3.35 -2.9% | 9/30/2021 | Initiated by | Bloom Burton | Analyst Prasath Pandurangan | Buy | $49.00 | Low | View details for Bloom Burton rating of Repare Therapeutics (NASDAQ:RPTX) on 9/30/2021 |
MDNA Medicenna Therapeutics | C$2.36 +2.2% | 9/22/2021 | Initiated by | Bloom Burton | Analyst Prasath Pandurangan | Buy | C$11.00 | N/A | View details for Bloom Burton rating of Medicenna Therapeutics (TSE:MDNA) on 9/22/2021 |
HLS HLS Therapeutics | C$3.34 -1.8% | 8/5/2021 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 8/5/2021 |
VMD Viemed Healthcare | $8.55 -3.7% | 8/4/2021 | Upgraded by | Bloom Burton | Analyst P. Pandurangan | Accumulate -> Buy | | Low | View details for Bloom Burton rating of Viemed Healthcare (NASDAQ:VMD) on 8/4/2021 |
AUPH Aurinia Pharmaceuticals | $7.21 -2.0% | 5/7/2021 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | High | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 5/7/2021 |
GUD Knight Therapeutics | C$5.64 +0.7% | 3/26/2021 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 3/26/2021 |
RX BioSyent | C$10.81 -3.9% | 3/18/2021 | Downgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Hold | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/18/2021 |
MDP Medexus Pharmaceuticals | C$2.38 -6.7% | 2/23/2021 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of Medexus Pharmaceuticals (TSE:MDP) on 2/23/2021 |
EPIX ESSA Pharma | $5.20 -1.5% | 2/12/2021 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 2/12/2021 |
CRHM CRH Medical | $3.99
| 1/8/2021 | Downgraded by | Bloom Burton | Analyst D. Martin | Hold | $3.00 | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 1/8/2021 |
CRHM CRH Medical | $3.99
| 12/23/2020 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 12/23/2020 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 11/17/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/17/2020 |
AUPH Aurinia Pharmaceuticals | $7.21 -2.0% | 11/3/2020 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | Low | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 11/3/2020 |
VMD Viemed Healthcare | $8.55 -3.7% | 10/19/2020 | Reiterated by | Bloom Burton | Analyst P. Pandurangan | Accumulate | | High | View details for Bloom Burton rating of Viemed Healthcare (NASDAQ:VMD) on 10/19/2020 |
RPTX Repare Therapeutics | $3.35 -2.9% | 9/17/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | High | View details for Bloom Burton rating of Repare Therapeutics (NASDAQ:RPTX) on 9/17/2020 |
HTL Hamilton Thorne | C$1.45 +4.3% | 8/21/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Hamilton Thorne (CVE:HTL) on 8/21/2020 |
XENE Xenon Pharmaceuticals | $41.11 -1.9% | 8/13/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | $25.00 | Medium | View details for Bloom Burton rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 8/13/2020 |
CRH CRH | $95.45 -0.5% | 8/14/2020 | Reiterated by | Bloom Burton | - | Buy | | Low | View details for Bloom Burton rating of CRH (NYSE:CRH) on 8/14/2020 |
CRHM CRH Medical | $3.99
| 8/13/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | $4.00 | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 8/13/2020 |
CRHM CRH Medical | $3.99
| 8/12/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | High | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 8/12/2020 |
HLS HLS Therapeutics | C$3.34 -1.8% | 7/21/2020 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 7/21/2020 |
Banking failure dead ahead (Ad) If you missed it, my emergency election broadcast is now available - but will be removed soon Click here to watch it now. |
GUD Knight Therapeutics | C$5.64 +0.7% | 6/29/2020 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 6/29/2020 |
ZYME Zymeworks | $13.70 -1.2% | 6/14/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | Low | View details for Bloom Burton rating of Zymeworks (NYSE:ZYME) on 6/14/2020 |
EPIX ESSA Pharma | $5.20 -1.5% | 5/24/2020 | Reiterated by | Bloom Burton | - | Buy | $9.00 | High | View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 5/24/2020 |
CPH Cipher Pharmaceuticals | C$15.04 -3.3% | 5/8/2020 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Accumulate | | N/A | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 5/8/2020 |
HLS HLS Therapeutics | C$3.34 -1.8% | 3/31/2020 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 3/31/2020 |
RX BioSyent | C$10.81 -3.9% | 3/19/2020 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/19/2020 |
AUPH Aurinia Pharmaceuticals | $7.21 -2.0% | 3/19/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | $23.00 | Low | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 3/19/2020 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 11/12/2019 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/12/2019 |
GUD Knight Therapeutics | C$5.64 +0.7% | 10/22/2019 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 10/22/2019 |
HLS HLS Therapeutics | C$3.34 -1.8% | 10/4/2019 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 10/4/2019 |
AUPH Aurinia Pharmaceuticals | $7.21 -2.0% | 10/2/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | Low | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 10/2/2019 |
RX BioSyent | C$10.81 -3.9% | 8/26/2019 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 8/26/2019 |
CPH Cipher Pharmaceuticals | C$15.04 -3.3% | 8/12/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Hold | | N/A | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 8/12/2019 |
HLS HLS Therapeutics | C$3.34 -1.8% | 8/9/2019 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 8/9/2019 |
CRHM CRH Medical | $3.99
| 8/1/2019 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 8/1/2019 |
MDP Medexus Pharmaceuticals | C$2.38 -6.7% | 7/3/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of Medexus Pharmaceuticals (TSE:MDP) on 7/3/2019 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 5/16/2019 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 5/16/2019 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 4/1/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 4/1/2019 |
HLS HLS Therapeutics | C$3.34 -1.8% | 3/22/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 3/22/2019 |
CPH Cipher Pharmaceuticals | C$15.04 -3.3% | 3/20/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 3/20/2019 |
CXRXF ADVANZ PHARMA | $17.06
| 3/15/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Hold | | Low | View details for Bloom Burton rating of ADVANZ PHARMA (OTCMKTS:CXRXF) on 3/15/2019 |
GUD Knight Therapeutics | C$5.64 +0.7% | 11/9/2018 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 11/9/2018 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 3/26/2018 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 3/26/2018 |
RX BioSyent | C$10.81 -3.9% | 3/22/2018 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/22/2018 |
EPI ESSA Pharma | C$8.20 +7.2% | 1/18/2018 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | N/A | View details for Bloom Burton rating of ESSA Pharma (CVE:EPI) on 1/18/2018 |
EPIX ESSA Pharma | $5.20 -1.5% | 1/18/2018 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | High | View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 1/18/2018 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 11/3/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/3/2017 |
HTL Hamilton Thorne | C$1.45 +4.3% | 10/25/2017 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Hamilton Thorne (CVE:HTL) on 10/25/2017 |
EPIX ESSA Pharma | $5.20 -1.5% | 9/12/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | Low | View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 9/12/2017 |
CPH Cipher Pharmaceuticals | C$15.04 -3.3% | 8/14/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | N/A | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 8/14/2017 |
CRHM CRH Medical | $3.99
| 7/14/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 7/14/2017 |
EPIX ESSA Pharma | $5.20 -1.5% | 5/18/2017 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | Low | View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 5/18/2017 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 5/15/2017 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 5/15/2017 |
CPH Cipher Pharmaceuticals | C$15.04 -3.3% | 5/12/2017 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | N/A | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 5/12/2017 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 5/9/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Hold | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 5/9/2017 |
CRHM CRH Medical | $3.99
| 2/24/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 2/24/2017 |
RX BioSyent | C$10.81 -3.9% | 2/13/2017 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 2/13/2017 |
CPH Cipher Pharmaceuticals | C$15.04 -3.3% | 2/13/2017 | Reiterated by | Bloom Burton | Analyst D. Martin | Hold | | N/A | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 2/13/2017 |
ABUS Arbutus Biopharma | $3.85 -2.3% | 1/9/2017 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of Arbutus Biopharma (NASDAQ:ABUS) on 1/9/2017 |
XENE Xenon Pharmaceuticals | $41.11 -1.9% | 12/22/2016 | Initiated by | Bloom Burton | - | Buy | $14.50 | N/A | View details for Bloom Burton rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 12/22/2016 |
ABUS Arbutus Biopharma | $3.85 -2.3% | 12/14/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of Arbutus Biopharma (NASDAQ:ABUS) on 12/14/2016 |
GUD Knight Therapeutics | C$5.64 +0.7% | 11/10/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 11/10/2016 |
AUPH Aurinia Pharmaceuticals | $7.21 -2.0% | 11/4/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 11/4/2016 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 11/2/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/2/2016 |
CRHM CRH Medical | $3.99
| 10/28/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 10/28/2016 |
ACHV Achieve Life Sciences | $4.68 -1.1% | 5/3/2013 | Target Raised by | Bloom Burton | - | Buy | $4,000.00 -> $5,000.00 | N/A | View details for Bloom Burton rating of Achieve Life Sciences (NASDAQ:ACHV) on 5/3/2013 |
ACHV Achieve Life Sciences | $4.68 -1.1% | 3/8/2013 | Target Raised by | Bloom Burton | - | | $3,600.00 -> $4,000.00 | N/A | View details for Bloom Burton rating of Achieve Life Sciences (NASDAQ:ACHV) on 3/8/2013 |
ONC Oncolytics Biotech | C$1.59 -3.6% | 12/18/2012 | Downgraded by | Bloom Burton | - | Buy -> Hold | | N/A | View details for Bloom Burton rating of Oncolytics Biotech (TSE:ONC) on 12/18/2012 |
THTX Theratechnologies | $1.21 -3.2% | 6/25/2012 | Downgraded by | Bloom Burton | - | Hold -> Sell | $2.50 -> $0.75 | N/A | View details for Bloom Burton rating of Theratechnologies (NASDAQ:THTX) on 6/25/2012 |
ACHV Achieve Life Sciences | $4.68 -1.1% | 5/4/2012 | Target Lowered by | Bloom Burton | - | Buy | $3,800.00 -> $3,600.00 | N/A | View details for Bloom Burton rating of Achieve Life Sciences (NASDAQ:ACHV) on 5/4/2012 |
Banking failure dead ahead (Ad) If you missed it, my emergency election broadcast is now available - but will be removed soon Click here to watch it now. |